Press Releases from Exactitude Consultancy (19422 total)
Retinoblastoma Market to Reach USD 1.2 Billion by 2034
Retinoblastoma is a rare pediatric eye cancer that originates in the retina and primarily affects children under five years of age. It accounts for around…
Severe Toxicities in Lymphoma Market Projected to Reach USD 3.7 Billion by 2034
Lymphoma, a group of blood cancers affecting the lymphatic system, is broadly classified into Hodgkin's lymphoma (HL) and non-Hodgkin's lymphoma (NHL). While survival outcomes have…
Soft Tissue Neoplasms Market to Reach USD 6.0 Billion by 2034
Soft tissue neoplasms are abnormal growths arising from connective tissues, including muscles, fat, nerves, tendons, and blood vessels. While some are benign, malignant forms such…
Mycosis Fungoides (MF) Market 2025-2034 Business Outlook, Critical Insight and G …
Introduction
Mycosis fungoides (MF) is the most common subtype of cutaneous T-cell lymphoma (CTCL), a rare non-Hodgkin's lymphoma that originates in skin-homing T-cells. MF typically presents…
T-Cell Blood Cancer Market is Expected to Reach USD 9.0 Billion by 2034
T-cell blood cancers are a heterogeneous group of aggressive hematologic malignancies that include T-cell acute lymphoblastic leukemia (T-ALL), peripheral T-cell lymphomas (PTCLs), and cutaneous T-cell…
Gene Therapy in Oncology Market Insights and Future Outlook
Introduction
Gene therapy is transforming oncology by introducing therapies that target cancer at the genetic and molecular level, offering potential cures where conventional treatments fall short.…
Chemotherapy-Induced Peripheral Neuropathy (CIPN) Market Growing Focus and Marke …
Introduction
Chemotherapy-induced peripheral neuropathy (CIPN) is a common and debilitating side effect of cancer treatment, caused by damage to peripheral nerves from drugs such as platinum…
Thymic Carcinoma Market is expected to double by 2034, reaching USD 1.1 billion
Thymic carcinoma is a rare and aggressive epithelial tumor originating in the thymus gland, accounting for a small fraction of mediastinal malignancies but associated with…
Thyroid Cancer Market Projected to Reach USD 7.6 Billion by 2034
Thyroid cancer is one of the most rapidly increasing cancers worldwide, arising in the thyroid gland at the base of the neck. While most thyroid…
Cholangiocarcinoma (CCA) Market Growth, Trends, Consumer Demand and Key Opportun …
Introduction
Cholangiocarcinoma (CCA), or bile duct cancer, is a rare but aggressive malignancy that arises from the epithelial cells of the bile ducts. It is categorized…
Triple Negative Breast Neoplasms Market is expected to reach USD 8.0 billion by …
Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer that lacks expression of estrogen receptors (ER), progesterone receptors (PR), and HER2. Representing…
Castrate-Sensitive Prostate Cancer Market Set to Witness Significant Growth by 2 …
Introduction
Prostate cancer remains one of the most commonly diagnosed cancers in men worldwide. Within this space, castrate-sensitive prostate cancer (CSPC) refers to prostate cancer that…
Acute Myeloid Leukemia (AML) Market 2025-2034 Business Outlook, Critical Insight …
Introduction
Acute myeloid leukemia (AML) is an aggressive hematologic malignancy characterized by the uncontrolled proliferation of abnormal myeloid cells in the bone marrow and blood. AML…
Triple Refractory Multiple Myeloma Market to Reach USD 6.0 Billion by 2034
Multiple myeloma (MM) is a malignancy of plasma cells that remains incurable despite major therapeutic advances. Patients often receive combinations of proteasome inhibitors (PIs), immunomodulatory…
Wilms Tumor Market Emerging Trends and Growth Prospects 2034
Introduction
Wilms tumor, or nephroblastoma, is a rare pediatric kidney cancer that typically affects children under the age of 5. Representing nearly 6% of all childhood…
Tumor Infiltrating Lymphocytes (TIL) Market to Reach USD 2.1 Billion by 2034
Tumor infiltrating lymphocytes (TILs) are immune cells that migrate into tumors and play a critical role in the body's natural defense against cancer. Harnessing these…
Uterine Leiomyosarcoma Market is expected to reach USD 1.2 billion by 2034
Uterine leiomyosarcoma (uLMS) is a rare but highly aggressive subtype of soft tissue sarcoma that originates in the smooth muscle layer of the uterus. Unlike…
Uveal Neoplasms Market Detailed Industry Report Analysis 2025-2034
Introduction
Uveal neoplasms, also referred to as uveal melanomas and related tumors, are rare malignancies that arise from the uveal tract of the eye, which includes…
Vulvar Cancer Market is expected to nearly double by 2034, reaching USD 850 mill …
Vulvar cancer is a rare gynecologic malignancy that arises on the external female genitalia, most commonly as squamous cell carcinoma, though melanoma, adenocarcinoma, and sarcoma…
Upper Tract Urothelial Cancer Market Set to Witness Significant Growth by 2025-2 …
Introduction
Upper tract urothelial cancer (UTUC) is a rare and aggressive malignancy that originates in the lining of the renal pelvis and ureters. Accounting for only…
Acute Lymphoblastic Leukemia Market to Double by 2034, Reaching USD 7.5 Billion
Acute lymphoblastic leukemia (ALL) is an aggressive cancer of the blood and bone marrow, characterized by the overproduction of immature lymphocytes. It is the most…
TRK Fusion Cancer Market Set to Witness Significant Growth by 2025-2034
TRK Fusion Cancer Market Outlook 2024-2034: Targeted Therapies and Precision Medicine Transform Rare Oncology Care
Introduction
TRK fusion cancer is a rare form of cancer caused by…
Cancer Anorexia Market Expected to Reach USD 3.5 Billion by 2034
Cancer anorexia, often linked with cancer cachexia, is a debilitating condition characterized by loss of appetite, reduced food intake, and progressive weight loss in cancer…
Triple Negative Cancer Market 2025-2034 Business Outlook, Critical Insight and G …
Introduction
Triple negative breast cancer (TNBC) is an aggressive subtype of breast cancer that lacks the expression of estrogen receptor (ER), progesterone receptor (PR), and HER2.…
Chemotherapy-Induced Neutropenia Market to Reach USD 11.9 Billion by 2034
Chemotherapy remains a cornerstone of cancer treatment, but one of its most serious side effects is chemotherapy-induced neutropenia (CIN) - a condition characterized by a…
Transitional Cell Carcinoma Market to Set Phenomenal Growth From 2025 to 2034
Introduction
Transitional cell carcinoma (TCC), also referred to as urothelial carcinoma, is the most common type of bladder cancer and also occurs in the renal pelvis,…
Thymus Cancer Market Detailed Industry Report Analysis 2025-2034
Introduction
Thymus cancer, a rare malignancy that originates in the thymus gland located in the anterior mediastinum, remains a significant clinical challenge due to its low…
T-Cell Prolymphocytic Leukemia Market Set to Witness Significant Growth by 2025- …
Introduction
T-cell prolymphocytic leukemia (T-PLL) is an extremely rare and aggressive hematologic malignancy, accounting for less than 2% of all mature lymphocytic leukemias. Characterized by rapid…
Soft Tissue Sarcoma with Lung Metastases Market Set to Witness Significant Growt …
Introduction
Soft tissue sarcomas (STS) are a diverse group of rare cancers that originate in connective tissues such as muscle, fat, nerves, and blood vessels. One…
Small Lymphocytic Lymphoma Market 2025-2034 Business Outlook, Critical Insight a …
Introduction
Small lymphocytic lymphoma (SLL) is a slow-growing, indolent type of non-Hodgkin's lymphoma (NHL) that is closely related to chronic lymphocytic leukemia (CLL). Despite being relatively…
Rhabdomyosarcoma Market Set to Witness Significant Growth by 2025-2034
Introduction
Rhabdomyosarcoma (RMS) is a rare but aggressive type of soft tissue sarcoma that arises from skeletal muscle progenitors. Most commonly affecting children and adolescents, RMS…
Renal Cell Carcinoma Market 2025-2034 Business Outlook, Critical Insight and Gro …
Introduction
Renal cell carcinoma (RCC) is the most common form of kidney cancer, accounting for nearly 90% of all kidney malignancies. Historically treated with surgery and…
Relapsed or Refractory Mycosis Fungoides Market 2025-2034 Business Outlook, Crit …
Introduction
Mycosis fungoides, the most common form of cutaneous T-cell lymphoma (CTCL), is a rare non-Hodgkin's lymphoma that primarily affects the skin. While early-stage disease can…
Refractory Multiple Myeloma Market Insights and Future Outlook
Introduction
Multiple myeloma is a hematologic malignancy that affects plasma cells in the bone marrow. Despite progress in treatment, many patients eventually develop refractory multiple myeloma…
Recurrent Head and Neck Cancer Squamous Cell Carcinoma Market Outlook 2024-2034
Introduction
Head and neck squamous cell carcinoma (HNSCC) is one of the most aggressive forms of cancer, with a high rate of recurrence despite advances in…
Relapsed Chronic Lymphocytic Leukemia Market to Reach USD 19.5 Billion by 2034
Chronic lymphocytic leukemia (CLL) is the most common type of adult leukemia in Western countries, characterized by the accumulation of dysfunctional B lymphocytes. While initial…
Recurrent Malignant Glioma Market Expected to Hit USD 4.0 Billion by 2034
Gliomas are the most common malignant brain tumors, arising from glial cells in the central nervous system. While initial treatment usually involves surgery, radiotherapy, and…
Radiotherapy-Induced Oral Mucositis Market to Set Phenomenal Growth From 2025 to …
Introduction
Radiotherapy is one of the most widely used cancer treatments, but it comes with significant side effects - one of the most debilitating being oral…
Recurrent Glioblastoma Market is expected to reach USD 3.5 billion by 2034
Glioblastoma multiforme (GBM) is the most aggressive and common malignant primary brain tumor in adults. Despite surgery, radiotherapy, and chemotherapy, most patients relapse, leading to…
Pheochromocytoma Market Emerging Trends and Growth Prospects 2034
Introduction
Pheochromocytoma is a rare tumor arising from adrenal gland chromaffin cells, often associated with excessive catecholamine secretion that leads to hypertension and cardiovascular complications. Although…
Pediatric Central Nervous System (CNS) Tumors Market Outlook 2024-2034
Introduction
Pediatric central nervous system (CNS) tumors are the most common solid tumors in children and the second leading cause of cancer-related deaths among young patients…
PD-L1 Non-Small Cell Lung Cancer Market Projected to Reach USD 41.8 Billion by 2 …
Lung cancer remains the leading cause of cancer-related deaths worldwide, with non-small cell lung cancer (NSCLC) accounting for nearly 85% of cases. Over the past…
Paraganglioma Market Detailed Industry Report Analysis 2025-2034
Introduction
Paraganglioma is a rare type of neuroendocrine tumor that originates from extra-adrenal chromaffin cells and can occur in the head, neck, thorax, or abdomen. Despite…
Pediatric Neuroblastoma Market to Reach USD 2.6 Billion by 2034
Neuroblastoma is the most common extracranial solid tumor in children, typically affecting infants and young children under the age of five. Arising from immature nerve…
PD-L1 Metastatic Non-Small Cell Lung Cancer Market is expected to double by 2034 …
Non-small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancer cases, with metastatic NSCLC being the most advanced and life-threatening form. Over…
Papilloma Market is Expected to Reach USD 2.7 Billion by 2034
Papillomas are benign epithelial tumors often associated with human papillomavirus (HPV) infections, though they may also arise from other viral or non-viral factors. While papillomas…
Pancreatic Ductal Carcinoma Market to Hit USD 11.2 Billion by 2034
Pancreatic ductal carcinoma (PDAC) is the most common type of pancreatic cancer, accounting for more than 90% of cases, and is one of the deadliest…
Atopic Dermatitis Market is expected to double by 2034, reaching USD 13.1 billio …
Atopic dermatitis (AD), also known as eczema, is a chronic inflammatory skin disorder that affects millions worldwide, characterized by intense itching, redness, and recurrent flare-ups.…
Alopecia Areata market is expected to reach USD 3.3 billion by 2034, indicating …
Alopecia areata is an autoimmune disorder that results in unpredictable hair loss, affecting millions of people globally. While not life-threatening, the condition has a profound…
Airway Stent Market Projected to Reach USD 2.5 Billion by 2034
Airway stents play a vital role in maintaining airway patency in patients with obstructive pulmonary diseases, lung cancer, tracheobronchial strictures, and other airway complications. These…
Go To Page: 21 22 23 24 25 26 27 28 29 30 251 252 253 254 255 256 257 258 259 260
